{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:42:40Z","timestamp":1787794960981,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Development Program of Jinan Municipal Health Commission","award":["2024304033"],"award-info":[{"award-number":["2024304033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06839-y","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:24:48Z","timestamp":1769401488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for early mortality (within 6 weeks of diagnosis) in Chinese children with acute leukemia: a single-center retrospective cohort study"],"prefix":"10.1007","volume":"105","author":[{"given":"Li\u2019an","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"6839_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1470-2045(23)00318-2","volume":"24","author":"BS Ehrlich","year":"2023","unstructured":"Ehrlich BS, McNeil MJ, Pham LTD, Chen Y, Rivera J, Acuna C, Sniderman L, Sakaan FM, Aceituno AM, Villegas CA, Force LM, Bolous NS, Wiphatphumiprates PP, Slone JS, Carrillo AK, Gillipelli SR, Duffy C, Arias AV, Devidas M, Rodriguez-Galindo C, Mukkada S, Agulnik A (2023) Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Oncol 24:967\u2013977. https:\/\/doi.org\/10.1016\/S1470-2045(23)00318-2","journal-title":"Lancet Oncol"},{"key":"6839_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"6839_CR3","doi-asserted-by":"publisher","first-page":"204062072412568","DOI":"10.1177\/20406207241256894","volume":"15","author":"JN Li","year":"2024","unstructured":"Li JN, Chen YJ, Fan Z, Li QR, Liao LH, Ke ZY, Li Y, Wang LN, Yang CY, Luo XQ, Tang YL, Zhang XL, Huang LB (2024) Intensive chemotherapy with dual induction and ALL-like consolidation for childhood acute myeloid leukemia: a respective report from multiple centers in China. Ther Adv Hematol 15:20406207241256894. https:\/\/doi.org\/10.1177\/20406207241256894","journal-title":"Ther Adv Hematol"},{"key":"6839_CR4","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1182\/blood.2023021952","volume":"143","author":"B Buldini","year":"2024","unstructured":"Buldini B, Varotto E, Maurer-Granofszky M, Gaipa G, Schumich A, Br\u00fcggemann M, Mejstrikova E, Cazzaniga G, Hrusak O, Szczepanowski M, Scarparo P, Zimmermann M, Strehl S, Schinnerl D, Zaliova M, Karawajew L, Bourquin JP, Feuerstein T, Cario G, Alten J, M\u00f6ricke A, Biffi A, Parasole R, Fagioli F, Valsecchi MG, Biondi A, Locatelli F, Attarbaschi A, Schrappe M, Conter V, Basso G, Dworzak MN (2024) CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment. Blood 143:1738\u20131751. https:\/\/doi.org\/10.1182\/blood.2023021952","journal-title":"Blood"},{"key":"6839_CR5","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1200\/JCO.22.02836","volume":"41","author":"J Li","year":"2023","unstructured":"Li J, Gao J, Liu A, Liu W, Xiong H, Liang C, Fang Y, Dai Y, Shao J, Yu H, Wang L, Wang L, Yang L, Yan M, Zhai X, Shi X, Tian X, Ju X, Chen Y, Wang J, Zhang L, Liang H, Chen S, Zhang J, Cao H, Jin J, Hu Q, Wang J, Wang Y, Zhou M, Han Y, Zhang R, Zhao W, Wang X, Lin L, Zhang R, Gao C, Xu L, Zhang Y, Fan J, Wu Y, Lin W, Yu J, Qi P, Huang P, Peng X, Peng Y, Wang T, Zheng H (2023) Homoharringtonine-based induction regimen improved the remission rate and survival rate in Chinese childhood AML: a report from the CCLG-AML 2015 protocol study. J Clin Oncol 41:4881\u20134892. https:\/\/doi.org\/10.1200\/JCO.22.02836","journal-title":"J Clin Oncol"},{"key":"6839_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/BLCTT.S245210","volume":"11","author":"C Bender","year":"2021","unstructured":"Bender C, Maese L, Carter-Febres M, Verma A (2021) Clinical utility of Pegaspargase in children, adolescents and young adult patients with acute lymphoblastic leukemia: a review. Blood Lymphat Cancer 11:25\u201340. https:\/\/doi.org\/10.2147\/BLCTT.S245210","journal-title":"Blood Lymphat Cancer"},{"key":"6839_CR7","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","volume":"33","author":"CM Zwaan","year":"2015","unstructured":"Zwaan CM, Kolb EA, Reinhardt D, Abrahamsson J, Adachi S, Aplenc R, De Bont ES, De Moerloose B, Dworzak M, Gibson BE, Hasle H, Leverger G, Locatelli F, Ragu C, Ribeiro RC, Rizzari C, Rubnitz JE, Smith OP, Sung L, Tomizawa D, van den Heuvel-Eibrink MM, Creutzig U, Kaspers GJ (2015) Collaborative efforts driving Rrogress in pediatric acute myeloid leukemia. J Clin Oncol 33:2949\u20132962. https:\/\/doi.org\/10.1200\/JCO.2015.62.8289","journal-title":"J Clin Oncol"},{"key":"6839_CR8","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"CH Pui","year":"2015","unstructured":"Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, Vora A, Baruchel A, Silverman LB, Schmiegelow K, Escherich G, Horibe K, Benoit YC, Izraeli S, Yeoh AE, Liang DC, Downing JR, Evans WE, Relling MV, Mullighan CG (2015) Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 33:2938\u20132948. https:\/\/doi.org\/10.1200\/JCO.2014.59.1636","journal-title":"J Clin Oncol"},{"key":"6839_CR9","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1200\/JCO.20.02370","volume":"39","author":"LA Mattano Jr","year":"2021","unstructured":"Mattano LA Jr., Devidas M, Maloney KW, Wang C, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick NS, Matloub YH, Marshall DT, Stork LC, Loh ML, Raetz EA, Wood BL, Hunger SP, Carroll WL, Winick NJ (2021) Favorable trisomies and ETV6-RUNX1 predict cure in low-risk B-cell acute lymphoblastic leukemia: results from children\u2019s oncology group trial AALL0331. J Clin Oncol 39:1540\u20131552. https:\/\/doi.org\/10.1200\/JCO.20.02370","journal-title":"J Clin Oncol"},{"key":"6839_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-025-02353-1","volume":"10","author":"L Chang","year":"2025","unstructured":"Chang L, Gao J, Lei X, He Y, Zhuang S, Li C, Weng K, Wang L, Guo X, Liu Q, Wang P, Zhuang Y, Yan M, Liu W, Chen H, Zhang M, Shen S, Zhu X, Ju X, Zhang L, Wang Z (2025) A multicenter single-arm clinical study of Chinese children\u2019s cancer group-acute promyelocytic leukemia-2017 (CCCG-APL-2017) protocol. Signal Transduct Target Ther 10:267. https:\/\/doi.org\/10.1038\/s41392-025-02353-1","journal-title":"Signal Transduct Target Ther"},{"key":"6839_CR11","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.3324\/haematol.2024.285285","volume":"109","author":"B Zeller","year":"2024","unstructured":"Zeller B, Arad-Cohen N, Cheuk D, De Moerloose B, Navarro JMF, Hasle H, Jahnukainen K, Juul-Dam KL, Kaspers G, Kovalova Z, Jonsson OG, Lausen B, Munthe-Kaas M, Nystrom UN, Palle J, Pasauliene R, Pronk CJ, Saks K, Tierens A, Abrahamsson J (2024) Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol. Haematologica 109:2873\u20132883. https:\/\/doi.org\/10.3324\/haematol.2024.285285","journal-title":"Haematologica"},{"key":"6839_CR12","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","volume":"11","author":"SH O\u2019Brien","year":"2024","unstructured":"O\u2019Brien SH, Rodriguez V, Lew G, Newburger JW, Schultz CL, Orgel E, Derr K, Ranalli MA, Esbenshade AJ, Hochberg J, Kang HJ, Dinikina Y, Mills D, Donovan M, Dyme JL, Favatella NA, Mitchell LG (2024) Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial. Lancet Haematol 11:e27\u2013e37. https:\/\/doi.org\/10.1016\/S2352-3026(23)00314-9","journal-title":"Lancet Haematol"},{"key":"6839_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00134-024-07454-z","volume":"50","author":"A Lafarge","year":"2024","unstructured":"Lafarge A, Chean D, Whiting L, Clere-Jehl R (2024) Management of hematological patients requiring emergency chemotherapy in the intensive care unit. Intensive Care Med 50:849\u2013860. https:\/\/doi.org\/10.1007\/s00134-024-07454-z","journal-title":"Intensive Care Med"},{"key":"6839_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4143\/crt.2021.313","volume":"54","author":"KM Park","year":"2022","unstructured":"Park KM, Yoo KH, Kim SK, Lee JW, Chung NG, Ju HY, Koo HH, Lyu CJ, Han SM, Han JW, Choi JY, Hong KT, Kang HJ, Shin HY, Im HJ, Koh KN, Kim H, Kook H, Baek HJ, Kim BR, Yang EJ, Lim JY, Park ES, Choi EJ, Park SK, Lee JM, Shim YJ, Kim JY, Park JK, Kong SG, Choi YB, Cho B, Lim YT (2022) Clinical characteristics and treatment outcomes of childhood acute promyelocytic leukemia in korea: a nationwide multicenter retrospective study by Korean pediatric oncology study group. Cancer Res Treat 54:269\u2013276. https:\/\/doi.org\/10.4143\/crt.2021.313","journal-title":"Cancer Res Treat"},{"key":"6839_CR15","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/cam4.2889","volume":"9","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Yang R, Cai J, Yu J, Tang Y, Chen Y, Wang N, He H, Wu X, Cheng FWT, Sun L, He Y, Ju X, Tian X, Hu Q, Jin R, Pan K, Fang Y, Zhai X, Jiang H, Li CK (2020) Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in china: a multicenter study CCCG-ALL-2015. Cancer Med 9:2113\u20132121. https:\/\/doi.org\/10.1002\/cam4.2889","journal-title":"Cancer Med"},{"key":"6839_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/08880018.2020.1871453","volume":"38","author":"S Seetharam","year":"2021","unstructured":"Seetharam S, Thankamony P, Gopakumar KG, Nair RA, Jacob PM, Jagathnath Krishna KM, Rajeswari B, Nair M, Guruprasad CS, Prasanth VR (2021) Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: analysis of an institutional series from India. Pediatr Hematol Oncol 38:358\u2013366. https:\/\/doi.org\/10.1080\/08880018.2020.1871453","journal-title":"Pediatr Hematol Oncol"},{"key":"6839_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3760\/cma.j.cn112140-20200430-00454","volume":"58","author":"X Chen","year":"2020","unstructured":"Chen X, Liu F, Guo Y, Zhao BB, Zhang RR, Yang WY, Chen XJ, Zhu XF (2020) Diagnosis and treatment efficacy analysis of 29 children with mixed phenotype acute leukemia. Zhonghua Er Ke Za zhi\u2009=\u2009Chinese. J Pediatr 58:807\u2013812. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20200430-00454","journal-title":"J Pediatr"},{"key":"6839_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1182\/blood-2016-06-721662","volume":"128","author":"A DA","year":"2016","unstructured":"DA A, MJ AORHJT, MM B LB, CD B, M C, JW V (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 128:462\u2013463. https:\/\/doi.org\/10.1182\/blood-2016-06-721662","journal-title":"Blood"},{"key":"6839_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-4608(88)90087-8","volume":"30","author":"SMCS Group","year":"1988","unstructured":"Group SMCS (1988) Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Report of the workshop held in Leuven, Belgium, September 15\u201317, 1986. Second MIC cooperative study group. Cancer Genet Cytogenet 30:1\u201315. https:\/\/doi.org\/10.1016\/0165-4608(88)90087-8","journal-title":"Cancer Genet Cytogenet"},{"key":"6839_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12967-025-06773-z","volume":"23","author":"M Wang","year":"2025","unstructured":"Wang M, Zhou Q, Cao T, Li F, Li X, Zhang M, Zhou Y (2025) Lactate dehydrogenase A: a potential new target for tumor drug resistance intervention. J Transl Med 23:713. https:\/\/doi.org\/10.1186\/s12967-025-06773-z","journal-title":"J Transl Med"},{"key":"6839_CR21","doi-asserted-by":"publisher","first-page":"16869","DOI":"10.1021\/acs.jmedchem.5c00182","volume":"68","author":"W Pan","year":"2025","unstructured":"Pan W, Tao C, Wu Y, Jiang F (2025) A medicinal chemistry perspective on lactate dehydrogenase: current status and future directions. J Med Chem 68:16869\u201316900. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c00182","journal-title":"J Med Chem"},{"key":"6839_CR22","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/bloodadvances.2022008284","volume":"7","author":"S Liu","year":"2023","unstructured":"Liu S, Xiang Y, Wang B, Gao C, Chen Z, Xie S, Wu J, Liu Y, Zhao X, Yang C, Yue Z, Wang L, Wen X, Zhang R, Zhang F, Xu H, Zhai X, Zheng H, Zhang H, Qian M (2023) USP1 promotes the aerobic Glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1\/LDHA axis. Blood Adv 7:3099\u20133112. https:\/\/doi.org\/10.1182\/bloodadvances.2022008284","journal-title":"Blood Adv"},{"key":"6839_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","volume":"81","author":"Y Qing","year":"2021","unstructured":"Qing Y, Dong L, Gao L, Li C, Li Y, Han L, Prince E, Tan B, Deng X, Wetzel C, Shen C, Gao M, Chen Z, Li W, Zhang B, Braas D, Ten Hoeve J, Sanchez GJ, Chen H, Chan LN, Chen CW, Ann D, Jiang L, M\u00fcschen M, Marcucci G, Plas DR, Li Z, Su R, Chen J (2021) R-2-hydroxyglutarate attenuates aerobic Glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis. Mol Cell 81:922\u2013939e929. https:\/\/doi.org\/10.1016\/j.molcel.2020.12.026","journal-title":"Mol Cell"},{"key":"6839_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3760\/cma.j.cn121090-20240917-00351","volume":"46","author":"MH Su","year":"2025","unstructured":"Su MH, Yan ZS, Li QL, Zhang JY, Yin YK, Hu B, Liu YZ, Li DP, Mi YC (2025) Analysis of risk factors for early death in hyperleukocytic acute leukemia. Zhonghua Xue Ye Xue Za Zhi 46:53\u201357. https:\/\/doi.org\/10.3760\/cma.j.cn121090-20240917-00351","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"6839_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12957-023-02965-3","volume":"21","author":"ZM Yuan","year":"2023","unstructured":"Yuan ZM, Wang LH, Chen C (2023) Prognostic value of serum \u03b1-HBDH levels in patients with lung cancer. World J Surg Oncol 21:78. https:\/\/doi.org\/10.1186\/s12957-023-02965-3","journal-title":"World J Surg Oncol"},{"key":"6839_CR26","doi-asserted-by":"publisher","first-page":"e38815","DOI":"10.7759\/cureus.38815","volume":"15","author":"ON Dukmak","year":"2023","unstructured":"Dukmak ON, Ayyad M, Albandak M, Hamadah A, Gharaibeh K (2023) Tumor genesis syndrome presenting as severe hypophosphatemia in a patient with T-cell acute lymphoblastic leukemia. Cureus 15:e38815. https:\/\/doi.org\/10.7759\/cureus.38815","journal-title":"Cureus"},{"key":"6839_CR27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00431-017-2899-7","volume":"176","author":"WK Chan","year":"2017","unstructured":"Chan WK, Chang KO, Lau WH (2017) Tumour genesis syndrome: severe hypophosphatemia and hypokalemia May be ominous presenting findings in childhood acute myeloid leukaemia. Eur J Pediatr 176:1137\u20131141. https:\/\/doi.org\/10.1007\/s00431-017-2899-7","journal-title":"Eur J Pediatr"},{"key":"6839_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1600-0609.2005.00547.x","volume":"75","author":"TD Filippatos","year":"2005","unstructured":"Filippatos TD, Milionis HJ, Elisaf MS (2005) Alterations in electrolyte equilibrium in patients with acute leukemia. Eur J Haematol 75:449\u2013460. https:\/\/doi.org\/10.1111\/j.1600-0609.2005.00547.x","journal-title":"Eur J Haematol"},{"key":"6839_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/0886022X.2020.1735417","volume":"42","author":"Y Li","year":"2020","unstructured":"Li Y, Chen X, Shen Z, Wang Y, Hu J, Xu J, Shen B, Ding X (2020) Electrolyte and acid-base disorders in cancer patients and its impact on clinical outcomes: evidence from a real-world study in China. Ren Fail 42:234\u2013243. https:\/\/doi.org\/10.1080\/0886022X.2020.1735417","journal-title":"Ren Fail"},{"key":"6839_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/CLEP.S454263","volume":"16","author":"Y Choi","year":"2024","unstructured":"Choi Y, Kim BK, Won JH, Yoo JW, Choi W, Jung S, Kim JY, Choi IY, Chung NG, Lee JW, Choi JY, Kang HJ, Lee H (2024) A study to evaluate the effectiveness and safety of prephase steroid treatment before remission induction chemotherapy in patients with pediatric acute lymphoblastic leukemia using common data model-based real-world data: a retrospective observational study. Clin Epidemiol 16:293\u2013304. https:\/\/doi.org\/10.2147\/CLEP.S454263","journal-title":"Clin Epidemiol"},{"key":"6839_CR31","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.1038\/s41598-021-88912-2","volume":"11","author":"Y Xue","year":"2021","unstructured":"Xue Y, Chen J, Gao S, Zhai X, Wang N, Gao J, Lv Y, Yin M, Zhuang Y, Zhang H, Zhu X, Wu X, Li CK, Hu S, Liang C, Jin R, Jiang H, Yang M, Sun L, Pan K, Cai J, Tang J, Guan X, Fang Y (2021) Clinical characteristics of tumor Lysis syndrome in childhood acute lymphoblastic leukemia. Scie Rep 11:9656. https:\/\/doi.org\/10.1038\/s41598-021-88912-2","journal-title":"Scie Rep"},{"key":"6839_CR32","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/cells9102310","volume":"9","author":"JP Bewersdorf","year":"2020","unstructured":"Bewersdorf JP, Zeidan AM (2020) Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better Understanding of the underlying molecular pathophysiology lead to novel treatments? Cells 9:2310. https:\/\/doi.org\/10.3390\/cells9102310","journal-title":"Cells"},{"key":"6839_CR33","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.jtha.2024.03.020","volume":"22","author":"Y Hisada","year":"2024","unstructured":"Hisada Y, Archibald SJ, Bansal K, Chen Y, Dai C, Dwarampudi S, Balas N, Hageman L, Key NS, Bhatia S, Bhatia R, Mackman N, Gangaraju R (2024) Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia. J Thromb Haemostasis: J Thromb Haemost 22:1984\u20131996. https:\/\/doi.org\/10.1016\/j.jtha.2024.03.020","journal-title":"J Thromb Haemostasis: J Thromb Haemost"},{"key":"6839_CR34","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/cncr.34728","volume":"129","author":"D Nguyen","year":"2023","unstructured":"Nguyen D, Kantarjian HM, Short NJ, Qiao W, Ning J, Cuglievan B, Daver NG, DiNardo CD, Jabbour EJ, Kadia TM, Borthakur G, Garcia-Manero G, Konopleva MY, Andreeff M, Ravandi-Kashani F, Sasaki K, Issa GC (2023) Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer 129:1856\u20131865. https:\/\/doi.org\/10.1002\/cncr.34728","journal-title":"Cancer"},{"key":"6839_CR35","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.3390\/cancers15133477","volume":"15","author":"J Hermsen","year":"2023","unstructured":"Hermsen J, Hambley B (2023) The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management. Cancers 15:3477. https:\/\/doi.org\/10.3390\/cancers15133477","journal-title":"Cancers"},{"key":"6839_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/diagnostics15030383","volume":"15","author":"B Strasser","year":"2025","unstructured":"Strasser B, Mustafa S, Seier J, Tomasits J, Haushofer A (2025) Hematopathological patterns in acute myeloid leukemia with complications of overt disseminated intravascular coagulation. Diagnostics (Basel) 15:383. https:\/\/doi.org\/10.3390\/diagnostics15030383","journal-title":"Diagnostics (Basel)"},{"key":"6839_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/cncr.35109","volume":"130","author":"J Ruiz","year":"2024","unstructured":"Ruiz J, Li Y, Cao L, Huang YV, Tam V, Griffis HM, Winestone LE, Fisher BT, Alonzo TA, Wang YJ, Dang AT, Kolb EA, Glanz K, Getz KD, Aplenc R, Seif AE (2024) Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia. Cancer 130:962\u2013972. https:\/\/doi.org\/10.1002\/cncr.35109","journal-title":"Cancer"},{"key":"6839_CR38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00520-021-06471-8","volume":"30","author":"RAM Silva","year":"2022","unstructured":"Silva RAM, de Mendon\u00e7a RMH, Dos Santos Aguiar S, Yajima JC, Marson FAL, Brandalise SR, Levy CE (2022) Induction therapy for acute lymphoblastic leukemia: incidence and risk factors for bloodstream infections. Support Care Cancer 30:695\u2013702. https:\/\/doi.org\/10.1007\/s00520-021-06471-8","journal-title":"Support Care Cancer"},{"key":"6839_CR39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","volume":"124","author":"D O\u2019Connor","year":"2014","unstructured":"O\u2019Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, Vora A, Goulden N, Samarasinghe S (2014) Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood 124:1056\u20131061. https:\/\/doi.org\/10.1182\/blood-2014-03-560847","journal-title":"Blood"},{"key":"6839_CR40","doi-asserted-by":"publisher","first-page":"e242727","DOI":"10.1001\/jamanetworkopen.2024.2727","volume":"7","author":"KP Goggin","year":"2024","unstructured":"Goggin KP, Lu L, Lee DE, Howell CR, Srivastava D, Brinkman TM, Armstrong GT, Bhakta N, Robison LL, Ehrhardt MJ, Hudson MM, Krull KR, Pui CH, Rubnitz J, Ness KK, Wolf J (2024) Severe sepsis during treatment for childhood leukemia and sequelae among adult survivors. JAMA Netw Open 7:e242727. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.2727","journal-title":"JAMA Netw Open"},{"key":"6839_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/SLA.0000000000006140","volume":"280","author":"ST Papastefan","year":"2024","unstructured":"Papastefan ST, Zeineddin S, Blakely ML, Lovvorn HN, Huang LW, Raval MV, Lautz TB (2024) Association of prophylactic antibiotics with early infectious complications in children with cancer undergoing central venous access device placement. Ann Surg 280:1021\u20131028. https:\/\/doi.org\/10.1097\/SLA.0000000000006140","journal-title":"Ann Surg"},{"key":"6839_CR42","doi-asserted-by":"publisher","first-page":"21142","DOI":"10.1038\/s41598-021-00725-5","volume":"11","author":"TC Yeh","year":"2021","unstructured":"Yeh TC, Hou JY, Huang TH, Lu CH, Sun FJ, Huang HM, Liu HC (2021) Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia. Sci Rep 11:21142. https:\/\/doi.org\/10.1038\/s41598-021-00725-5","journal-title":"Sci Rep"},{"key":"6839_CR43","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/cncr.34751","volume":"129","author":"GE Christakopoulos","year":"2023","unstructured":"Christakopoulos GE, Walker KN, Smith J, Takemoto CM, Zheng Y, Pui CH, Ribeiro RC, Wang L, Pounds SB, Rubnitz JE, Inaba H (2023) Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods. Cancer 129:1873\u20131884. https:\/\/doi.org\/10.1002\/cncr.34751","journal-title":"Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06839-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:03:52Z","timestamp":1771398232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06839-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6839"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06839-y","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Children\u2019s Hospital Affiliated with Shandong University in China (approval number: SDFE-IRB\/T-2025122). All patients included in this study are under 16 years of age. Due to the retrospective nature of this study, the consent from legal guardians of all patients was waived by the above ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}